Showing results (1131-1140 of 1,161) with videos related to
Sort By:
Pageof 117
Journal of the American Chemical Society|June 18, 2015
Highly Selective, Reversible Inhibitor Identified by Comparative Chemoproteomics Modulates Diacylglycerol Lipase Activity in NeuronsMarc P Baggelaar, Pascal J P Chameau, Vasudev Kantae, et al.World Journal of Emergency Surgery : WJES|April 9, 2020
Surgery in COVID-19 patients: operational directivesFederico Coccolini, Gennaro Perrone, Massimo Chiarugi, et al.Frontiers in Cellular Neuroscience|May 4, 2023
Activation of cannabinoid type 1 receptor (CB1) modulates oligodendroglial process branching complexity in rat hippocampal cultures stimulated by olfactory ensheathing glia-conditioned mediumYolanda Paes-Colli, Priscila M P Trindade, Louise C Vitorino, et al.Journal of Medicinal Chemistry|February 19, 2016
Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and PainMargherita Brindisi, Samuele Maramai, Sandra Gemma, et al.Journal of Medicinal Chemistry|January 19, 2024
Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. SARs, Structural Analysis, and Biological CharacterizationStefania Butini, Uwe Grether, Kwang-Mook Jung, et al.BMC Cancer|November 26, 2016
Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trialFrancesco Caponigro, Elena Di Gennaro, Franco Ionna, et al.Thescientificworldjournal|June 25, 2020
Mesotherapy: From Historical Notes to Scientific Evidence and Future ProspectsMassimo Mammucari, Enrica Maggiori, Domenico Russo, et al.Prostate Cancer and Prostatic Diseases|March 18, 2025
Hypofractionated radiotherapy in elderly patients (≥75 years) affected by localized prostate cancer: a multicenter retrospective analysis from the IPOPROMISE studyGianluca Ingrosso, Eleonora Festa, Saverio Caini, et al.European Heart Journal|November 25, 2011
The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaquesFabrizio Montecucco, Vincenzo Di Marzo, Rafaela F da Silva, et al.BMC Cancer|September 11, 2019
Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocolAlessandro Ottaiano, Stefania Scala, Nicola Normanno, et al.Pageof 117